It was roughly 24 hours between Senator Zuiderveld emailing Director Bailey and the OGI removing the coverage of the weight loss medications
Brown hopes that Medicaid will soon cover GLP-1s specifically for weight loss, because obesity isnt just a cosmetic issue
Retrieved from Zipursky, J
In real-world settings there is an array of factors that may contribute to non-persistence, including medication supply shortages, adverse effects, high out-of-pocket costs and real-world weight reduction not meeting the patients expectations.
Concurrent lifestyle interventionsregular exercise, sleep optimization, stress management, and adequate hydrationdirectly reduce anxiety and improve GLP-1 tolerability
Read more about why weight regain happens after stopping GLP-1 and how to avoid it